aminophylline has been researched along with Encephalopathy, Toxic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhn, AK; Rubin, MF | 1 |
| Chan, CH; Kao, WY; Liao, PF; Peng, TR | 1 |
| Haque, AU; Jabbar, N; Mirza, S; Razi, W; Sadiq, H; Ullah, R | 1 |
| Ando, Y; Irie, T; Irikura, M; Ishitsuka, Y; Ito, S; Moriuchi, H; Somekawa-Kondo, T; Takahama, K; Tanaka, K; Yamaguchi, K; Yamazaki, T | 1 |
| Jaksic, W; Lewis, I; Pozza, C; Veljkovic, D | 1 |
| Crews, KR; Daw, NC; Inaba, H; Khan, RB; Laningham, FH; Pui, CH | 1 |
| Cociglio, M; Hansel, S; Hillaire-Buys, D; Margueritte, G; Peyriere, H; Poiree, M | 1 |
7 other study(ies) available for aminophylline and Encephalopathy, Toxic
| Article | Year |
|---|---|
Management of methotrexate-induced neurotoxicity with aminophylline plus dextromethorphan in a pediatric patient with pineoblastoma.
Topics: Adolescent; Aminophylline; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bronchodilator Agents; Cisplatin; Cyclophosphamide; Dextromethorphan; Disease Management; Drug Therapy, Combination; Etoposide; Excitatory Amino Acid Antagonists; Female; Humans; Methotrexate; Neurotoxicity Syndromes; Pineal Gland; Pinealoma; Prognosis | 2020 |
High-Dose Aminophylline for Methotrexate-Induced Neurotoxicity in a Patient With Brain Metastasis.
Topics: Aminophylline; Brain; Brain Neoplasms; Humans; Methotrexate; Neurotoxicity Syndromes | 2021 |
Safety and Efficacy of Aminophylline in Intrathecal Methotrexate-related Neurological Toxicity in Large Pediatric Oncology Centre.
Topics: Aminophylline; Child; Humans; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2021 |
Aminophylline, administered at usual doses for rodents in pharmacological studies, induces hippocampal neuronal cell injury under low tidal volume hypoxic conditions in guinea-pigs.
Topics: Aminophylline; Animals; Antipyrine; CA1 Region, Hippocampal; Creatine Kinase, BB Form; Disease Models, Animal; Dose-Response Relationship, Drug; Edaravone; Free Radical Scavengers; Glutathione; Guinea Pigs; Hypoxia, Brain; Infusions, Intravenous; Lipid Peroxides; Male; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Oxidative Stress; Phosphodiesterase Inhibitors; Phosphopyruvate Hydratase; Purinergic P1 Receptor Antagonists; Theophylline | 2013 |
Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.
Topics: Adult; Aminophylline; Brain Diseases; Female; Humans; Leucovorin; Magnetic Resonance Imaging; Methotrexate; Neurotoxicity Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2004 |
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
Topics: Acute Disease; Adolescent; Aminophylline; Antimetabolites, Antineoplastic; Bone Neoplasms; Brain; Child; Diffusion Magnetic Resonance Imaging; Female; Histiocytoma, Malignant Fibrous; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Male; Metabolic Clearance Rate; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2008 |
Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
Topics: Aminophylline; Antimetabolites, Antineoplastic; Child; Humans; Male; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency | 2001 |